New & Emerging Treatments

The New & Emerging Treatments webinar series is hosted annually by the Leukemia Research Foundation for leukemia patients, caregivers, family members, and healthcare professionals. Each hour-long program is dedicated to a specific subtype of leukemia, and addresses the latest treatments, ongoing research, and what's on the horizon, followed by a live Q & A.

Dr. Paul Koller - 200x250 - tighter

Chronic myeloid leukemia (CML)

TUESDAY, JUNE 17, 2025 I 11:00AM-12:00PM CT  (9:00 PT, 10:00 MT, 12:00 ET)

Paul Koller, MD, Assistant Professor, Division of Leukemia, Department of Hematology & Hematopoietic Cell Transplantation, City of Hope, addresses current CML treatments and shares what new treatments are on the horizon.

Catherine Coombs - 200x250

Chronic lymphocytic leukemia (CLL)

WEDNESDAY, June18, 2025 I 12:00PM-1:00PM CT  (10:00 PT, 11:00 MT, 1:00 ET)

Catherine Coombs, MD, Associate Clinical Professor, Division of Hematology/Oncology, Department of Medicine, UCI Health discusses current CLL treatments and what new treatments are on the horizon.

Mims - 200x250

Acute myeloid leukemia (AML)

MONDAY, June 23, 2025  I  7:00-8:00pm CT (5:00 PT, 6:00 MT, 8:00 ET)

Alice Mims, MD, The James Comprehensive Cancer Center, The Ohio State University addresses current AML treatments and shares what new treatments are on the horizon.

Mark Litzow - 200x250

Acute lymphocytic leukemia (ALL)

MONDAY, JUNE 23, 2025 I 8:00-9:00PM CT  (6:00 PT, 7:00 MT, 9:00 ET)

Mark R. Litzow, MD, Professor of Medicine, Division of Hematology, Mayo Clinic discusses current ALL treatments and what new treatments are on the horizon.

Program supporters

Astrazeneca-transparent-220px-w
Autolus - 200x50
Kite - 221x60
Merck - 221x60
Pfizer 221x60

Single session supporter

Vironexis - 200x50